Dihydromyricetin alleviates cerebral ischemia-reperfusion injury by attenuating apoptosis and astrogliosis in peri-infarct cortex

References

• Engelhardt E. Apoplexy, cerebrovascular disease, and stroke: historical evolution of terms and definitions. Dement Neuropsychol. 2017;11:449–453.
   PubMedGoogle Scholar
• GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459–480.
   PubMed Web of Science ®Google Scholar
• Campbell BC, Silva DA, Macleod MR, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019;5:70.
   PubMed Web of Science ®Google Scholar
• Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391–397.
   PubMed Web of Science ®Google Scholar
• Heiss WD. Flow thresholds of functional and morphological damage of brain tissue. Stroke. 1983;14:329–331.
   PubMed Web of Science ®Google Scholar
• Obrenovitch TP. The ischaemic penumbra: twenty years on. Cerebrovasc Brain Metab Rev. 1995;7:297–323.
   PubMedGoogle Scholar
• Seet RC, Rabinstein AA. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Cerebrovasc Dis. 2012;34:106–114.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Willey JZ, Cucchiara B, et al. American heart association stroke council; council on cardiovascular and stroke nursing; council on clinical cardiology; and council on quality of care and outcomes research. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2017;48:e343–e361.
   PubMed Web of Science ®Google Scholar
• Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke. 2009;40:e331–9.
   PubMed Web of Science ®Google Scholar
• Kou X, Chen N. Pharmacological potential of ampelopsin in rattan tea. Food Sci Hum Wellness. 2012;1:14–18.
   Google Scholar
• Murakami T, Miyakoshi M, Araho D, et al. Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. Biofactors. 2004;21:175–178.
   PubMed Web of Science ®Google Scholar
• Qi S, Xin Y, Guo Y, et al. Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int Immunopharmacol. 2012;12:278–287.
   PubMed Web of Science ®Google Scholar
• Liu S, Ai Q, Feng K, et al. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways. Apoptosis. 2016;21:1366–1385.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang J, Zhang H, et al. Dihydromyricetin inhibits oxidative stress and apoptosis in oxygen and glucose deprivation/reoxygenation‑induced HT22 cells by activating the Nrf2/HO-1 pathway. Mol Med Rep. 2021;23:397.
   PubMed Web of Science ®Google Scholar
• Qian X, Wang J, and Cao W, et al. Dihydromyricetin attenuates D-galactose-induced brain aging of mice via inhibiting oxidative stress and neuroinflammation. Neurosci Lett. 2021;756;135963.
   PubMed Web of Science ®Google Scholar
• Kou J, Li J, Bian Y, et al. Ampelopsin attenuates 6 - OHDA - induced neurotoxicity by regulating GSK - 3β/NRF2/ARE signalling. J Funct Foods. 2015;19:765–774.
   Web of Science ®Google Scholar
• Liang J, López-Valdés HE, Martínez-Coria H, et al. Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer’s disease. Neurochem Res. 2014;39:1171–1181.
   PubMed Web of Science ®Google Scholar
• Mu Y, Li B, Liu W, et al. Dihydromyricetin ameliorates 3NP-induced behavioral deficits and striatal injury in rats. J Mol Neurosci. 2016;60:267–275.
   PubMed Web of Science ®Google Scholar
• Ye XL, Lu LQ, Li W, et al. Oral administration of ampelopsin protects against acute brain injury in rats following focal cerebral ischemia. Exp Ther Med. 2017;13:1725–1734.
   PubMed Web of Science ®Google Scholar
• Longa EZ, Weinstein PR, and Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84–91 .
   PubMed Web of Science ®Google Scholar
• Rogers DC, Campbell CA, and Stretton JL, et al. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke. 1997;28:2060–2065 .
   PubMed Web of Science ®Google Scholar
• Moran PM, Higgins LS, Cordell B, et al. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci USA. 1995;92:5341–5345.
   PubMed Web of Science ®Google Scholar
• Bederson JB, Pitts LH, Germano SM, et al. Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304–1308.
   PubMed Web of Science ®Google Scholar
• Ren ZX, Zhao YF, Cao T, et al. Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson’s disease by suppressing glycogen synthase kinase-3 beta activity. Acta Pharmacol Sin. 2016;37:1315–1324.
   PubMed Web of Science ®Google Scholar
• Liu P, Zou D, Chen K, et al. Dihydromyricetin improves hypobaric hypoxia-induced memory impairment via modulation of SIRT3 signalling. Mol Neurobiol. 2016;53:7200–7212.
   PubMed Web of Science ®Google Scholar
• Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;407:802–809.
   PubMed Web of Science ®Google Scholar
• Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci. 1997;20:245–267.
   PubMed Web of Science ®Google Scholar
• Plesnila N, Zinkel S, Le DA, et al. Bid mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia. Proc Natl Acad Sci USA. 2001;98:15318–15323.
   PubMed Web of Science ®Google Scholar
• Tzifi F, Economopoulou C, Gourgiotis D, et al. The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv Hematol. 2012;2012:524308.
   PubMedGoogle Scholar
• Sugawara T, Fujimura M, Noshita N, et al. Neuronal death/survival signalling pathways in cerebral ischemia. NeuroRx. 2004;1:17–25.
   PubMedGoogle Scholar
• Endres M, Wang ZQ, Namura S, et al. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab. 1997;17:1143–1151.
   PubMed Web of Science ®Google Scholar
• Namura S, Zhu J, Fink K, et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci. 1998;18:3659–3668.
   PubMed Web of Science ®Google Scholar
• Liu G, Wang T, Wang T, et al. Effects of apoptosis-related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia rats. Biomed Rep. 2013;1:861–867.
   PubMedGoogle Scholar
• Bai X, Tan TY, Li YX, et al. The protective effect of cordyceps sinensis extract on cerebral ischemic injury via modulating the mitochondrial respiratory chain and inhibiting the mitochondrial apoptotic pathway. Biomed Pharmacother. 2020;124:109834.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Cao Y, Lu X, et al. Xanthohumol protects neuron from cerebral ischemia injury in experimental stroke. Mol Biol Rep. 2020;47:2417–2425.
   PubMed Web of Science ®Google Scholar
• Mullen RJ, Buck CR, Smith AM. NeuN, a neuronal specific nuclear protein in vertebrates. Development. 1992;116:201–211.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wu M, Peng C, et al. GFAP expression in injured astrocytes in rats. Exp Ther Med. 2017;14:1905–1908.
   PubMed Web of Science ®Google Scholar
• Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003;26:523–530.
   PubMed Web of Science ®Google Scholar
• Pekny M, Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol. 2004;20:428–437.
   Web of Science ®Google Scholar
• Fang SH, Wei EQ, Zhou Y, et al. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience. 2006;140:969–979.
   PubMed Web of Science ®Google Scholar
• Buchhold B, Mogoanta L, Suofu Y, et al. Environmental enrichment improves functional and neuropathological indices following stroke in young and aged rats. Restor Neurol Neurosci. 2007;25:467–484.
   PubMed Web of Science ®Google Scholar
• Liu XZ, Xu XM, Hu R, et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci. 1997;17(14):5395–5406.
   PubMed Web of Science ®Google Scholar
• Jin X, Riew TR, Kim HL, et al. Morphological characterization of NG2 glia and their association with neuroglial cells in the 3-nitropropionic acid-lesioned striatum of rat. Sci Rep. 2018;8(1):5942.
   PubMed Web of Science ®Google Scholar
• Tan Z, Turner RC, Leon RL, et al. Bryostatin improves survival and reduces ischemic brain injury in aged rats after acute ischemic stroke. Stroke. 2013;44(12):3490–3497.
   PubMed Web of Science ®Google Scholar